Marinus Pharmaceuticals reported $-39433000 in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.57M 79M
Aptinyx Inc APTX:US $ -17667000 2.16M
Biogen BIIB:US $ 874.8M 28.6M
Eisai 4523:JP Y 9722M 30501M
Enanta Pharmaceuticals ENTA:US $ -32.15M 1.44M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
Marinus Pharmaceuticals MRNS:US $ -39.43M 20.07M
Minerva Neurosciences NERV:US $ -8.72M 1.05M
Neurocrine Biosciences NBIX:US $ -23.3M 44.7M
Ptc Therapeutics PTCT:US $ -148.7M 26.8M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Supernus Pharmaceuticals SUPN:US $ 11.32M 3.4M